Page last updated: 2024-08-25

we 201 and Lung Diseases

we 201 has been researched along with Lung Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, WL; Cheng, KT; Cheng, TJ; Lin, CY; Yan, YH1
Arbibe, L; Béréziat, G; Faure, G; Havet, N; Koumanov, K; Longacre, S; Rougeot, C; Touqui, L; Vargaftig, BB; Vial, D; Voelker, DR; Wolf, C1

Other Studies

2 other study(ies) available for we 201 and Lung Diseases

ArticleYear
Alterations in rat pulmonary phosphatidylcholines after chronic exposure to ambient fine particulate matter.
    Molecular bioSystems, 2014, Volume: 10, Issue:12

    Topics: Animals; Chromatography, High Pressure Liquid; Lung; Lung Diseases; Lysophosphatidylcholines; Male; Particle Size; Particulate Matter; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry

2014
Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction.
    The Journal of clinical investigation, 1998, Sep-15, Volume: 102, Issue:6

    Topics: Acute Disease; Animals; Biosensing Techniques; Bronchoalveolar Lavage Fluid; Fatty Acids; Group II Phospholipases A2; Guinea Pigs; Hydrolysis; Indoles; Lipopolysaccharides; Lung Diseases; Lysophosphatidylcholines; Male; Palmitic Acid; Phospholipases A; Phospholipases A2; Protein Binding; Proteolipids; Pulmonary Surfactant-Associated Protein A; Pulmonary Surfactant-Associated Proteins; Pulmonary Surfactants

1998